Haibo Biotechnology
Ningbo
About Haibo Biotechnology
Haibo Biotechnology is a biotech company that specializes in hypoxic fluorescent targeted drugs for tumors such as head and neck cancer and prostate cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Funding stage: Seed
- Last round: Seed (Oct 2023)
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/haibo-biotechnology-3166264 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.